NRXS reports strong second-quarter 2025 revenue growth and lower losses, but gross margin compression remains a key concern.

Inspire Medical tops second-quarter 2025 earnings estimates and posts solid revenue growth, but trims 2025 guidance amid margin pressure.

HIMS records subscriber surge and revenue growth in second-quarter 2025, but rising costs strain gross margins.

HIMS records subscriber surge and revenue growth in second-quarter 2025, but rising costs strain gross margins.

TTD slides 30% pre-market despite strong revenue growth and CTV momentum, as Q2 EPS misses estimates by 2.4%.

TTD slides 30% pre-market despite strong revenue growth and CTV momentum, as Q2 EPS misses estimates by 2.4%.

ROCK's Q2 EPS rises 11% but misses estimates, while strong M&A and infrastructure gains drive 13% revenue growth.

ROCK's Q2 EPS rises 11% but misses estimates, while strong M&A and infrastructure gains drive 13% revenue growth.

Hims & Hers Health (HIMS) delivered earnings and revenue surprises of -5.56% and -1.51%, respectively, for the quarter ended June 2025. Do the numbers...

ONTO's second-quarter EPS missed estimates despite 5% revenue growth, fueled by strength in advanced nodes and AI packaging demand.